The nature of inflammation and tissue damage in COPD

P. J. Barnes (London, United Kingdom)

Source: Annual Congress 2004 - Acquired somatic mutations in the pathogenesis of COPD
Session: Acquired somatic mutations in the pathogenesis of COPD
Session type: Assembly Symposium
Number: 1640
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. J. Barnes (London, United Kingdom). The nature of inflammation and tissue damage in COPD. Annual Congress 2004 - Acquired somatic mutations in the pathogenesis of COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between markers of systemic inflammation and microstructural brain damage in COPD.
Source: International Congress 2019 – From the health effects of tobacco to the epidemiology of tobacco/electronic nicotine delivery system use
Year: 2019



Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Source: Eur Respir J 2008; 31: 1334-1356
Year: 2008



The role of inflammation in COPD
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



The role of oxidative damage in pathogenesis of experimental pulmonary emphysema
Source: Annual Congress 2007 - Unravelling molecular mysteries of COPD
Year: 2007


A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016


Aerobic training decreases perivascular inflammation and remodeling in a murine model of chronic allergic lung inflammation
Source: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel in vitro assays and results from animal models
Year: 2007


Investigation of relationships between inflammation and brain disease in COPD
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018




Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012


Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

The level of MDA in BALF might reflect oxidative tissue damage in patients with mild MAC pulmonary disease.
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020


IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011


The danger signal plus DNA damage two-hit hypothesis for chronic inflammation in COPD
Source: Eur Respir J 2013; 42: 1689-1695
Year: 2013



IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease
Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019
Year: 2021



The role of small-airway inflammation and remodeling in asthma
Source: Annual Congress 2013 –Small airways in asthma: from physiologic measures to clinical relevance
Year: 2013


Air pollution and biomarkers of systemic inflammation and tissue repair in COPD patients
Source: Eur Respir J 2014; 44: 603-613
Year: 2014



Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019


Lung and serum biomarkers of tissue lesions due to acute exacerbation of COPD
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012